Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Xianshihu Keli (Compound Dendrobium Granules) is an approved traditional Chinese medicine (TCM) herbal formula developed and manufactured by Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. It is formulated as oral granules (keli) and was identified as an independently developed national new drug in China, receiving an invention patent in 2000. The formula is primarily based on *Dendrobium* (Shihu) and is typically used in TCM to replenish yin and harmonize the stomach, particularly for conditions related to stomach-yin deficiency and gastrointestinal distress. As a multi-component herbal formula, it works through the synergistic effects of its constituent phytochemicals rather than a single defined biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fufang Xianshihu Keli.